Clinical trial
A Phase 1 Single Dose PK Study in Adolescent Subjects With Fragile X Syndrome or Angelman Syndrome
NCT03109756 is registered in ClinicalTrials.gov with Healx AI as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Single Dose PK Study in Adolescent Subjects With Fragile X Syndrome or Angelman Syndrome
- Lead sponsor
- Healx AI
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 3, 2017
- Completion date
- November 28, 2017
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.